87 results about "Hypoallergenic" patented technology

Disclosed are apparatuses and methods for the production of attenuated aseptic parasites in hematophagous insects generally, and production of Plasmodium species sporozoites in Anopheles species mosquitoes specifically; apparatuses and methods for the production of strains of hematophagous insects with desired properties such as hypoallergenicity or hyperinfectivity; methods of producing a parasite strain that is capable of withstanding cyropreservation at temperatures close to freezing; apparatuses and methods for the injection of an attenuated parasite vaccine; production of parasites and hematophagous insects that are free from contamination by unwanted biological agents; apparatuses for the reconstruction of complex parasitic life cycles aseptically to avoid the contamination of the parasite or the insect vector host with unwanted biological agents.

The present invention relates to the use of a solution containing at least one endopeptidase to substantially reduce or completely eliminate allergenic proteins contained in the peanut (Arachis hypogea). In particular, the direct application of a solution containing at least one endopeptidase to either raw, blanched, or roasted peanuts or peanut products or derivates, has been shown to substantially reduce or completely eliminate the activity of allergenic proteins. The treated peanuts showed no degradation in quality or sensory acceptability, and have the flavor and aroma of natural whole peanuts. Hypoallergenic or non-allergenic peanuts produced in accordance with the present invention may be used as ingredients in various food products and other edible materials.

The present invention generally relates to vulcanization compositions used to vulcanize elastomeric articles, where the vulcanization compositions have reduced allergenic potential as compared to elastomeric articles formed using vulcanization compositions having non-fugitive accelerators. The present invention also relates to elastomeric articles formed using the vulcanization compositions. The invention further relates to methods for making a reduced-allergenicity vulcanization composition, and to methods for using the vulcanization compositions to vulcanize elastomeric articles.

The invention discloses hypoallergenic newborn formula milk powder. The hypoallergenic newborn formula milk powder comprises the raw materials of raw milk, lactose, alpha-whey protein, whey protein hydrolysates, casein hydrolysate and bioactive substances. The invention further discloses a method for preparing the milk powder. The method comprises the following steps of (1) uniformly mixing the raw materials with water, and performing complete dissolving so as to obtain feed liquid A, wherein the raw materials comprise the raw milk, the lactose, the alpha-whey protein, the whey protein hydrolysates and the casein hydrolysate; (2) homogenizing the feed liquid A obtained in step (1), sterilizing the homogenized feed liquid A, concentrating the sterilized feed liquid A and performing spray drying so as to obtain a material B; and (3) uniformly mixing bioactive substances in the raw materials with the material B in a dry-mixing workshop so as to obtain the hypoallergenic newborn formula milk powder. The hypoallergenic newborn formula milk powder disclosed by the invention has the advantages of taking account of being hypoallergenic and improving immunity, so that the problem of causing allergic reaction of babies is solved through reducing anaphylactogen and improving immunity. The preparation technology is simple, the milk powder is good in solubility, the shelf life is stable, and the milk powder is not liable to oxidize.

A hypoallergenic adhesive article employing a switchable pressure sensitive adhesive (PSA) composition comprising one or more amphiphilic polyesters in physical mixture with a humectant. When contacted with a liquid of low-ion content, the adhesive undergoes a reduction in peel strength, which allows for easy removal, but remains strongly adhered when contacted with ionic liquids, such as blood, sweat, and other bodily fluids. The adhesive composition can be employed in a variety of medical articles or in other similar applications.

A nutritional composition for very low birth weight infants which comprises 26 5 to 38 g / l of a source of hypoallergenic hydrolysed whey protein with a degree of hydrolysis between 8 and 20, 37 to 46 g / l of a fat source of which 20 to 50% is medium chain triglycerides and which has an n6:n3 ratio between 6 and 12 and 50 to 100 g / l of a carbohydrate source which composition contains between 3.2 and 4.0 grams of protein per 100kcal.

The present invention relates to the use of a solution containing at least one endopeptidase to substantially reduce or completely eliminate allergenic proteins contained in the peanut (Arachis hypogea). In particular, the direct application of a solution containing at least one endopeptidase to either raw, blanched, or roasted peanuts or peanut products or derivates, has been shown to substantially reduce or completely eliminate the activity of allergenic proteins. The treated peanuts showed no degradation in quality or sensory acceptability, and have the flavor and aroma of natural whole peanuts. Hypoallergenic or non-allergenic peanuts produced in accordance with the present invention may be used as ingredients in various food products and other edible materials.

The present invention relates to new microorganism strains L.plantarum MCCl DSM 23881 and L.gasseri MCC2 DSM 23882 and their use as antioxidant proteolytic ingredients for the production of food products and dietary supplements. Food products and dietary supplements containing L.plantarum MCCl and L.gasseri MCC2 are hypoallergenic, reduce milk allergy and lower urinary tract irritation symptoms accompanying benign prostatic hyperplasia and oxidative stress and inflammation associated with these.

This invention is directed generally to compositions (including foods, supplements, treats, toys, etc.) for animal (including pet) consumption, and particularly hypoallergenic compositions, and more particularly semi-solid hypoallergenic compositions and hypoallergenic compositions that comprise a hydrolysate. This invention also is directed generally to methods for using such compositions. This invention is further directed generally to processes for making such compositions.

The invention provides novel hypoallergenic and non-irritant medical skin care formulations being water-in-oil emulsions. The formulations are free from ingredients with a known allergenic potential, such as fragrances, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins, thus being particularly suitable for patients with sensitive dry skin. The skin care formulations of the invention are useful in the prophylaxis and treatment of dry, sensitive skin or in the therapy or therapy support of eczematous or psoriatic skin and exhibit favorable sensorial properties. The invention furthermore provides a method of manufacturing the novel hypoallergenic and non-irritant skin care formulations.

A composition of chemically purified soluble mannans from legumes' seeds (e.g. Ceratonia siliqua, Caesalpinia spinosa Trigonelle foenum-graecum, and Cyamopsis tetragonolobus) and their use in the assembly of palatable dietary supplements is disclosed herein. The fractionation process provides high-quality physiologically soluble, chemically modified and purified homogeneous size polysaccharide fibers, devoid of natural impurities, for example proteins, alkaloids, glycoalkaloids, and / or environmental impurities including heavy metals, agricultural residues and microbial toxins. This process provides hypoallergenic dietary fibers devoid of any potential allergens, cytotoxins, and gastrointestinal toxins. A sequential process for assembly of the soluble fibers with plurality of molecular weights to create a time controlled dissolution of the functional high and low molecular weight fibers for improving solubility and palatability with improved dietary performance in the oral and gastro-intestinal system is also disclosed herein.

The invention provides a hypoallergenic soothing epidermis anesthesia cream as well as a preparation method and application thereof. The cream comprises the following components of 5-20 g of an anesthetic, 0.5-2 g of a soothing agent, 8-15 g of an emulsifier, 8-15 g of a thickener and the balance of 900-950 ml of purified water. By adding specific soothing components, the sensitization risk caused by lidocaine and prilocaine can be greatly reduced, and particularly, the cream can also effectively relieve postoperative adverse reactions.